New research is being presented at ACC 14, the American College of Cardiology’s 63rd Annual Scientific Session & Expo, from March 29-31 in Washington, DC.
Meeting Highlights
Celiac Disease Increases CAD Risk
Onsite Cardiac Surgery Impacts PCI Outcomes
Validating Atherosclerotic CVD Pooled Cohort Risk Equations
Test Could Quickly Rule Out MI
Comparing Bariatric Surgery & Medical Therapy for Diabetes
Renal Denervation for Uncontrolled Hypertension
Balloon- Vs Self-Expandable TAVR
Aspirin Use in Non-Cardiac Surgery
News From the Meeting
Evaluation of Low-Dose Clonidine and Aspirin in Patients at Risk For ASCVD
TAVR With a Self-Expanding Prosthesis Shows Lower Mortality Than Surgery
One-Third of Children Tested in Texas Have Borderline or High Cholesterol
One-Year Results Show Real-World TAVR Procedures Consistent With Clinical Trials
Studies Suggest Coronary Calcium Scores Can Assess Long-Term Risk for Heart Disease
McNamara Lecture to Detail the Power of Congenital Heart Diseases Incremental Progress
Using Data to Drive Health Care
Studies Highlight Innovative Strategies for Reducing Hospital Readmissions
Perspectives: Debates in Hypertension
LAPLACE-2 and GAUSS-2 Explore Different Aspects of PCSK9 Use
Aleglitazar to Reduce CV Events in Patients With ACS and Diabetes
Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy
DESCARTES, MENDEL-2, RUTHERFORD-2 Trials Look at Impacts of Evolocumab
Validation of Pooled Cohorts 10-Year Atherosclerotic CVD Risk Equations
Is ‘Spring Ahead’ a Heart Risk?
New ACC/AHA/HRS Guideline Addresses Management of Patients With AFib
Vascular Disease, Marital Status Linked?
Metformin No Help in MI Recovery
Still No Clear CHOICE for TAVI
Statins Tied to Boost in Men’s Sexual Function
More From the Meeting
About the Walter E. Washington Convention Center
Ticketed Sessions & Additional Options
